STOCK TITAN

Cybin to Present at the Canaccord Genuity 42nd Annual Growth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Cybin Inc. announced that CEO Doug Drysdale will participate in a fireside chat during the Canaccord Genuity 42nd Annual Growth Conference, set for August 8-11, 2022 at the InterContinental Boston Hotel. The event will be webcast live on August 11, 2022 at 3:30 p.m. ET. Interested parties can access the live event and subsequent archived webcast on the Company's investor relations website.

Founded in 2019, Cybin is dedicated to developing safe and effective therapeutics for mental health issues, leveraging innovative technologies and partnerships.

Positive
  • None.
Negative
  • None.

TORONTO, Ontario--(BUSINESS WIRE)-- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to TherapeuticsTM” is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will participate in a fireside chat at the Canaccord Genuity 42nd Annual Growth Conference being held at the InterContinental Boston Hotel on August 8-11, 2022.

Mr. Drysdale’s fireside chat will be webcast live on Thursday, August 11, 2022 at 3:30 p.m. ET. To listen to the event, please click here to access the webcast. The archived webcast will also be available on the Company’s investor relations website on the Events & Presentations page.

About Cybin

Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. The Company is focused on progressing Psychedelics to Therapeutics by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders.

Investor & Media:

Leah Gibson

Vice President, Investor Relations & Strategic Communications

Cybin Inc.

irteam@cybin.com – or – media@cybin.com

Source: Cybin Inc.

FAQ

When is Cybin's fireside chat at the Canaccord Genuity conference?

Cybin's fireside chat will take place on August 11, 2022, at 3:30 p.m. ET.

How can I access the webcast of Cybin's fireside chat?

You can access the live webcast of Cybin's fireside chat on their investor relations website.

What is Cybin's focus as a biopharmaceutical company?

Cybin focuses on advancing Psychedelics to Therapeutics for mental health treatment.

Where is the Canaccord Genuity conference being held?

The conference is being held at the InterContinental Boston Hotel.

What is the ticker symbol for Cybin?

The ticker symbol for Cybin is CYBN.

Cybin Inc.

NYSE:CYBN

CYBN Rankings

CYBN Latest News

CYBN Stock Data

202.33M
19.99M
6.35%
38.41%
3.28%
Biotechnology
Healthcare
Link
United States of America
Toronto